330 related articles for article (PubMed ID: 24404136)
1. Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle.
Johns N; Hatakeyama S; Stephens NA; Degen M; Degen S; Frieauff W; Lambert C; Ross JA; Roubenoff R; Glass DJ; Jacobi C; Fearon KC
PLoS One; 2014; 9(1):e83618. PubMed ID: 24404136
[TBL] [Abstract][Full Text] [Related]
2. New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.
Johns N; Stretch C; Tan BH; Solheim TS; Sørhaug S; Stephens NA; Gioulbasanis I; Skipworth RJ; Deans DA; Vigano A; Ross JA; Bathe OF; Tremblay ML; Kaasa S; Strasser F; Gagnon B; Baracos VE; Damaraju S; Fearon KC
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):122-130. PubMed ID: 27897403
[TBL] [Abstract][Full Text] [Related]
3. Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials.
Roeland EJ; Ma JD; Nelson SH; Seibert T; Heavey S; Revta C; Gallivan A; Baracos VE
Support Care Cancer; 2017 Feb; 25(2):365-369. PubMed ID: 27628947
[TBL] [Abstract][Full Text] [Related]
4. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis.
Martin L; Muscaritoli M; Bourdel-Marchasson I; Kubrak C; Laird B; Gagnon B; Chasen M; Gioulbasanis I; Wallengren O; Voss AC; Goldwasser F; Jagoe RT; Deans C; Bozzetti F; Strasser F; Thoresen L; Kazemi S; Baracos V; Senesse P
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1189-1202. PubMed ID: 34448539
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA).
Blum D; Stene GB; Solheim TS; Fayers P; Hjermstad MJ; Baracos VE; Fearon K; Strasser F; Kaasa S;
Ann Oncol; 2014 Aug; 25(8):1635-42. PubMed ID: 24562443
[TBL] [Abstract][Full Text] [Related]
7. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
8. The influence of different muscle mass measurements on the diagnosis of cancer cachexia.
Blauwhoff-Buskermolen S; Langius JAE; Becker A; Verheul HMW; de van der Schueren MAE
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):615-622. PubMed ID: 28447434
[TBL] [Abstract][Full Text] [Related]
9. Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden.
Hong N; Yoon HJ; Lee YH; Kim HR; Lee BW; Rhee Y; Kang ES; Cha BS; Lee HC
J Clin Endocrinol Metab; 2016 Mar; 101(3):1207-14. PubMed ID: 26765580
[TBL] [Abstract][Full Text] [Related]
10. HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia.
Huot JR; Novinger LJ; Pin F; Bonetto A
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31915140
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic criteria for the classification of cancer-associated weight loss.
Martin L; Senesse P; Gioulbasanis I; Antoun S; Bozzetti F; Deans C; Strasser F; Thoresen L; Jagoe RT; Chasen M; Lundholm K; Bosaeus I; Fearon KH; Baracos VE
J Clin Oncol; 2015 Jan; 33(1):90-9. PubMed ID: 25422490
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
13. Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia.
Narasimhan A; Ghosh S; Stretch C; Greiner R; Bathe OF; Baracos V; Damaraju S
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):405-416. PubMed ID: 28058815
[TBL] [Abstract][Full Text] [Related]
14. A prospective study examining cachexia predictors in patients with incurable cancer.
Vagnildhaug OM; Brunelli C; Hjermstad MJ; Strasser F; Baracos V; Wilcock A; Nabal M; Kaasa S; Laird B; Solheim TS
BMC Palliat Care; 2019 Jun; 18(1):46. PubMed ID: 31164115
[TBL] [Abstract][Full Text] [Related]
15. Myokines in treatment-naïve patients with cancer-associated cachexia.
de Castro GS; Correia-Lima J; Simoes E; Orsso CE; Xiao J; Gama LR; Gomes SP; Gonçalves DC; Costa RGF; Radloff K; Lenz U; Taranko AE; Bin FC; Formiga FB; de Godoy LGL; de Souza RP; Nucci LHA; Feitoza M; de Castro CC; Tokeshi F; Alcantara PSM; Otoch JP; Ramos AF; Laviano A; Coletti D; Mazurak VC; Prado CM; Seelaender M
Clin Nutr; 2021 Apr; 40(4):2443-2455. PubMed ID: 33190987
[TBL] [Abstract][Full Text] [Related]
16. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
17. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
[TBL] [Abstract][Full Text] [Related]
18. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
19. Autophagy is induced in the skeletal muscle of cachectic cancer patients.
Aversa Z; Pin F; Lucia S; Penna F; Verzaro R; Fazi M; Colasante G; Tirone A; Rossi Fanelli F; Ramaccini C; Costelli P; Muscaritoli M
Sci Rep; 2016 Jul; 6():30340. PubMed ID: 27459917
[TBL] [Abstract][Full Text] [Related]
20. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
